10x Genomics

$137.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.18 (-1.56%) Today
$0.00 (0.00%) As of 5:14 PM EST after-hours

Why Robinhood?

You can buy or sell 10x Genomics and other stocks, options, and ETFs commission-free!

About TXG

10x Genomics, Inc. Class A Common Stock, also called 10x Genomics, is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA. The listed name for TXG is 10x Genomics, Inc. Class A Common Stock.

CEO
Serge Saxonov
Employees
584
Headquarters
Pleasanton, California
Founded
2012
Market Cap
21.74B
Price-Earnings Ratio
Dividend Yield
Average Volume
821.02K
High Today
$140.87
Low Today
$136.17
Open Price
$140.01
Volume
418.89K
52 Week High
$166.31
52 Week Low
$48.78

Collections

TXG Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.30 per share
Actual
-$0.65 per share

You May Also Like